Modern Family Stars Get Stuck in Crowded Elevator

No good deed goes unpunished.

PICS: Candid Celeb Sightings

While on their way to a fundraiser for the Boys & Girls Club of Greater Kansas City on Friday night, three stars of ABC's hit sitcom Modern Family were trapped in a crowded elevator for almost an hour, ABC News reports.

Julie Bowen, Eric Stonestreet and Jesse Tyler Ferguson took pictures together during the ordeal, which Ferguson posted to his Twitter account.

"This is us right now. 45 minutes stuck in this elevator," Ferguson wrote, captioning the snapshot from the Sheraton Kansas City Hotel's third floor.

The actors were an hour late to the event after the Kansas City Fire Department rescued them, but they maintained a good sense of humor about their plight, reportedly joking about the ordeal on stage.

Read More..

WHO: Slight cancer risk after Japan nuke accident

LONDON (AP) — Two years after Japan's nuclear plant disaster, an international team of experts said Thursday that residents of areas hit by the highest doses of radiation face an increased cancer risk so small it probably won't be detectable.

In fact, experts calculated that increase at about 1 extra percentage point added to a Japanese infant's lifetime cancer risk.

"The additional risk is quite small and will probably be hidden by the noise of other (cancer) risks like people's lifestyle choices and statistical fluctuations," said Richard Wakeford of the University of Manchester, one of the authors of the report. "It's more important not to start smoking than having been in Fukushima."

The report was issued by the World Health Organization, which asked scientists to study the health effects of the disaster in Fukushima, a rural farming region.

On March 11, 2011, an earthquake and tsunami knocked out the Fukushima plant's power and cooling systems, causing meltdowns in three reactors and spewing radiation into the surrounding air, soil and water. The most exposed populations were directly under the plumes of radiation in the most affected communities in Fukushima, which is about 150 miles (240 kilometers) north of Tokyo.

In the report, the highest increases in risk are for people exposed as babies to radiation in the most heavily affected areas. Normally in Japan, the lifetime risk of developing cancer of an organ is about 41 percent for men and 29 percent for women. The new report said that for infants in the most heavily exposed areas, the radiation from Fukushima would add about 1 percentage point to those numbers.

Experts had been particularly worried about a spike in thyroid cancer, since radioactive iodine released in nuclear accidents is absorbed by the thyroid, especially in children. After the Chernobyl disaster, about 6,000 children exposed to radiation later developed thyroid cancer because many drank contaminated milk after the accident.

In Japan, dairy radiation levels were closely monitored, but children are not big milk drinkers there.

The WHO report estimated that women exposed as infants to the most radiation after the Fukushima accident would have a 70 percent higher chance of getting thyroid cancer in their lifetimes. But thyroid cancer is extremely rare and one of the most treatable cancers when caught early. A woman's normal lifetime risk of developing it is about 0.75 percent. That number would rise by 0.5 under the calculated increase for women who got the highest radiation doses as infants.

Wakeford said the increase may be so small it will probably not be observable.

For people beyond the most directly affected areas of Fukushima, Wakeford said the projected cancer risk from the radiation dropped dramatically. "The risks to everyone else were just infinitesimal."

David Brenner of Columbia University in New York, an expert on radiation-induced cancers, said that although the risk to individuals is tiny outside the most contaminated areas, some cancers might still result, at least in theory. But they'd be too rare to be detectable in overall cancer rates, he said.

Brenner said the numerical risk estimates in the WHO report were not surprising. He also said they should be considered imprecise because of the difficulty in determining risk from low doses of radiation. He was not connected with the WHO report.

Some experts said it was surprising that any increase in cancer was even predicted.

"On the basis of the radiation doses people have received, there is no reason to think there would be an increase in cancer in the next 50 years," said Wade Allison, an emeritus professor of physics at Oxford University, who also had no role in developing the new report. "The very small increase in cancers means that it's even less than the risk of crossing the road," he said.

WHO acknowledged in its report that it relied on some assumptions that may have resulted in an overestimate of the radiation dose in the general population.

Gerry Thomas, a professor of molecular pathology at Imperial College London, accused the United Nations health agency of hyping the cancer risk.

"It's understandable that WHO wants to err on the side of caution, but telling the Japanese about a barely significant personal risk may not be helpful," she said.

Thomas said the WHO report used inflated estimates of radiation doses and didn't properly take into account Japan's quick evacuation of people from Fukushima.

"This will fuel fears in Japan that could be more dangerous than the physical effects of radiation," she said, noting that people living under stress have higher rates of heart problems, suicide and mental illness.

In Japan, Norio Kanno, the chief of Iitate village, in one of the regions hardest hit by the disaster, harshly criticized the WHO report on Japanese public television channel NHK, describing it as "totally hypothetical."

Many people who remain in Fukushima still fear long-term health risks from the radiation, and some refuse to let their children play outside or eat locally grown food.

Some restrictions have been lifted on a 12-mile (20-kilometer) zone around the nuclear plant. But large sections of land in the area remain off-limits. Many residents aren't expected to be able to return to their homes for years.

Kanno accused the report's authors of exaggerating the cancer risk and stoking fear among residents.

"I'm enraged," he said.

___

Mari Yamaguchi in Tokyo and AP Science Writer Malcolm Ritter in New York contributed to this report.

__

Online:

WHO report: http://bit.ly/YDCXcb

Read More..

With record highs in sight, stocks face roadblocks

NEW YORK (Reuters) - If Wall Street needs to climb a wall of worry, it will have plenty of opportunity next week.

Major U.S. stock indexes will make another attempt at reaching all-time records, but the fitful pace that has dominated trading is likely to continue. Next Friday's unemployment report and the hefty spending cuts that look like they about to take effect will be at the forefront.

The importance of whether equities can reach and sustain those highs is more than Wall Street's usual fixation on numbers with psychological significance. Breaking through to uncharted territory is seen as a test of investors' faith in the rally.

"It's very significant," said Bucky Hellwig, senior vice president at BB&T Wealth Management in Birmingham, Alabama.

"The thinking is, there's just not enough there for an extended bull run," he said. "If we do break through (record highs), then maybe the charts and price action are telling us there's something better ahead."

Flare-ups in the euro zone's sovereign debt crisis and next Friday's report on the U.S. labor market could jostle the market, though U.S. job indicators have generally been trending in a positive direction.

Small- and mid-cap stocks hit lifetime highs in February. Now the Dow Jones industrial average <.dji> and the S&P 500 <.spx> are racing each other to the top. The Dow, made up of 30 stocks, is about 75 points - less than 1 percent - away from its record close of 14,164.53, which it hit on October 9, 2007. The broader S&P is still 3 percent away from its closing high of 1,565.15, also reached on October 9, 2007.

The advantage may be in the Dow's court. So far in 2013, it has gained 7.5 percent, beating the S&P 500 by about 1 percent.

THE RALLY AND THE REALITY CHECK

The Dow's relative strength owes much to its unique make-up and calculation, as well as to investors' recent preference for buying value stocks likely to generate steady reliable gains, rather than growth stocks.

But the more defensive stance illustrates how stock buyers are getting concerned about this year's rally. While investors don't want to miss out on gains, they're picking up companies that are less likely to decline as much as high-flying names - if a market correction comes.

The Russell Value Index <.rav> is up 7.6 percent for the year so far, outpacing the Russell Growth Index's <.rag> 5.7 percent rise. Within the realm of the S&P 500, the consumer staples sector led the market in February, gaining 3.1 percent.

There is some concern that growth-oriented names are being eclipsed by defensive bets, said Ryan Detrick, senior technical strategist at Schaeffer's Investment Research in Cincinnati.

"This isn't a be-all and end-all sell signal by any means, but we would feel much more comfortable if some of the more aggressive areas, like technology and small caps, would start to gain some leadership here," Detrick said.

Signs that investors are becoming concerned about the rally's pace is evident in the options market, where the ratio of put activity to call activity has recently shifted in favor of puts, which represent expectations for a stock to fall.

"We are seeing some put hedging in the financials, building up for the past month," said Henry Schwartz, president of options analytics firm Trade Alert in New York.

The put-to-call ratio representing an aggregate of about 562 financial stocks is 1:1, when normally, calls should be outnumbering puts.

Investors have no shortage of reasons to crave the relative safety of blue chips and defensive stocks. Although markets have mostly looked past uncertainty over Washington's plans to cut the deficit, fiscal policy negotiations still pose a risk to equities.

The $85 billion in spending cuts set to begin on Friday is expected to slow economic growth this year if policymakers do not reach a new deal. Markets so far have held firm despite the wrangling in Washington, but tangible economic effects could pinch stock prices going forward.

The International Monetary Fund warned that full implementation of the cuts would probably take at least 0.5 percentage point off U.S. growth this year.

EASY MONEY AND TEPID HIRING

Investors will also take in a round of economic data at a time when concerns are percolating that the market is being pushed up less by fundamentals and more by loose monetary policy around the world.

The main economic event will be Friday's non-farm payrolls report for February. The U.S. economy is expected to have added 160,000 jobs last month, only a tad higher than in January, in a sign the labor market is healing at a slow pace. The U.S. unemployment rate is forecast to hold steady at 7.9 percent.

While lackluster data has been a catalyst in the past for stock market gains as investors bet it would ensure continued stimulus from the Federal Reserve, that sentiment may be wearing thin.

Markets stumbled last week following worries that the Fed might wind down its quantitative easing program sooner than expected.

"It shows the underpinning of the market is being driven at this point by monetary policy," Hellwig said.

With investors questioning what is behind the rally, it will make a run to record highs even more significant, Hellwig added.

"There's smart people that are in the bull camp and the bear camp and the muddle-through camp," Hellwig said. "The fact that you can statistically, using historical evidence, make a case for going higher, lower, or staying the same makes this number very important this time around."

(Wall St Week Ahead runs every Friday. Comments or questions on this column can be emailed to: leah.schnurr(at)thomsonreuters.com)

(Reporting by Leah Schnurr; Additional reporting by Doris Frankel in Chicago; Editing by Jan Paschal)

Read More..

'Skyfall' Jameson Empire Awards Nominations

Daniel Craig's third outing as 007, Skyfall, has grown to become the most successful James Bond film ever and the biggest-ever U.K. box-office hit – and after winning two Academy Awards it now leads the pack for the 18th Jameson Empire Awards with six nominations. Read on for details and to vote for your favorite films and stars!

CLICK HERE TO VOTE for the Jameson Empire Awards 2013.

Pics: The 12 Most Amazing Movies of '12

Skyfall is up for Best Thriller, Best British Film, Best Director, Jameson Best Actor (Daniel Craig), Best Actress presented by Citroën (Dame Judi Dench), and Best Film presented by Sky Movies. Nipping at Bond's heels are The Avengers and The Hobbit: An Unexpected Journey, going head-to-head in five categories: Best Science-Fiction/Fantasy (with strong competition from Looper, Prometheus and Dredd 3D), The Art Of 3D presented by RealD (up against Life of Pi, Dredd 3D and Prometheus), Best Director and Best Film. Those films' stars, Robert Downey Jr. and Martin Freeman, will face off in the Jameson Best Actor category against Daniel Craig and Oscar-winners Daniel Day-Lewis (Lincoln) and Christoph Waltz (Django Unchained).

Among the other categories, Entertainment Tonight is presenting Best Male Newcomer, with Suraj Sharma (Life of Pi), Domhnall Gleeson (Anna Karenina), Rafe Spall (Life of Pi), Steve Oram (Sightseers) and Tom Holland (The Impossible) in the running.

For the full list of nominees, CLICK HERE.

Video: Craig on Showing 'Skyfall' Skin: 'It's a Living'

Pitched as an antidote to more formal, industry-voted awards, the Jameson Empire Awards are voted for entirely by the cinema-going public, who can now vote on the final short list of nominees comprised of many names and titles that may have missed out at other awards ceremonies.

Read More..

Wall Street edges up as data outweighs sequester

NEW YORK (Reuters) - Stocks rose modestly on Friday as strong economic data outweighed growth concerns in China and Europe and let investors brush off worries about the impact of expected across-the-board government spending cuts.

Stocks opened sharply lower as Asian factories slowed and European output fell, but most of the losses dissipated after a report showed U.S. manufacturing activity expanded last month at its fastest clip in 20 months and put the S&P 500 index on track for a slight weekly gain.

U.S. consumer confidence also rose in February as Americans turned more optimistic about the job market.

With government budget cuts set to begin on Friday, President Barack Obama blamed Republicans for failure to reach a compromise to avert the cuts, known as sequester. But the stock market appeared to have already priced in the failure by legislators to reach an agreement.

"The positive manufacturing data, better than expected, sends a signal the economy itself, and manufacturing in particular, is showing signs of strength - trumping any concern that people seem to have with the sequester cuts," said Terry Sandven, chief equity strategist at U.S. Bank Wealth Management in Minneapolis.

The Dow Jones industrial average <.dji> gained 40.43 points, or 0.29 percent, to 14,094.92. The Standard & Poor's 500 Index <.spx> added 4.01 points, or 0.26 percent, to 1,518.69. The Nasdaq Composite Index <.ixic> rose 9.56 points, or 0.30 percent, to 3,169.75.

For the week so far, the Dow is up 0.7 percent, the S&P 500 is up 0.2 percent and the Nasdaq is up 0.3 percent.

The low interest rates due to the Federal Reserve's accommodative monetary policy have helped equities continue to attract investors. The Dow is less than 1 percent away from its all-time intraday high of 14,198.10. Declines have been shallow and short-lived, with investors jumping in to buy on dips.

Intuitive Surgical jumped 8.7 percent to $554.43 after Cantor Fitzgerald analyst Jeremy Feffer upgraded the stock, saying the stock's more than 11 percent slide on Thursday was a gross overreaction to a news report.

Groupon Inc surged 12.2 percent to $5.08 a day after the online coupon company fired its chief executive officer in the wake of weak quarterly results.

Gap Inc rose 3 percent to $33.87 after reporting fourth-quarter earnings that beat expectations and boosting its dividend by 20 percent, while Salesforce.com Inc posted sales that beat forecasts, driving its stock up 7.1 percent to $181.28.

Chesapeake Energy Corp fell 2.2 percent to $19.71 after the U.S. Securities and Exchange Commission escalated its investigation into the company and its Chief Executive Aubrey McClendon for a controversial perk that granted him a share in each of the natural gas producer's wells.

(Additional reporting by Rodrigo Campos; Editing by Jan Paschal)

Read More..

Dillion Casey Nikita Season Three Interview 2013

From losing hands to losing power, every character on Nikita has had to come to terms with the loss of something major this season. But perhaps no one has given up more than Sean Pierce, who in the last episode was forced to fake his own death after Amanda framed him for multiple murders.

But as Dillon Casey tells ETonline, his character's funeral frustrations are directed at someone else in the coming weeks. That was just one of the intriguing tidbits he brought up during our interview today!

ETonline: What was your reaction when you found out Sean would have to fake his own death and join Division full-time?

Dillon Casey: I was excited about it. Sean had been kind of floating along the surface for a while, trying to figure out how he could work with these people -- he didn't like that Alex was a part of Division, but he kept coming back because he loves her and wanted to make sure she was safe. If it was up to him, Division would be destroyed so forcing him to be a part of it, especially in this way, was an amazing turning point for the character.

RELATED - TV's Most Devastating Death Scenes

ETonline: We saw him struggling with his decision after the fact last week. Will that continue or does he come to accept it?

Casey: I think that as a SEAL, he's very good at accepting a situation and moving forward. He's obviously torn up about the fact his life was turned upside down and he died a traitor and a murderer, but he know that's something he can't change. All he can do is accept that he's a part of Division now and needs to make the best of it. I think that a part of him thinks if he keeps working hard, he can figure out a way to get his life back, but all he can do right now is take things one day at a time.

ETonline: Does this have a positive or negative effect on Sean's relationship with Alex?

Casey: It changes their relationship. They had the added benefit of not spending every waking hour with each other, that's going to turn out to have been a good thing. Now, they're kind of stuck in prison together and a serious tension arises from that because Alex feels guilty for Sean's situation. Whether he likes it or not, Sean does feel a bit of resentment to all of them. He was given this choice to change his life, and he's not sure it was the best choice to make [plus,] he resents having to make the choice at all. There's this resentment that Sean feels, and now he can't even go into the field and back Alex up like he wants to because he’s injured. So Alex get partnered with Owen and it's a whole new set of problems they have to deal with.

VIDEO - Explosive New Nikita Promo

ETonline: What does Sean think of Owen?

Casey: Owen and Alex share this dark history; this violent past, and that kind of gives you some insight into the butterfly tattoo on Alex's back. Owen has a lot of tattoos as well and they can bond over what that represents, while Sean doesn't have that dark past to bond with Alex over. The fact that Owen is taking Sean's place in the field and has this shared past to bond over with Alex kind of leads to a lot of jealousy from Sean.

ETonline: What's it like for Sean to be trapped in Division while Alex is in the field?

Casey: He's going stir crazy and kind of taking it out on Alex. He's trying to find a way to be useful, but tactical work is not what he really wants to be doing. He's very versatile; there's an upcoming episode where Michael has to go out into the field and Sean is the only person left at Division, and he takes over seamlessly.

ETonline: Ryan made a speech about how Division can be used for good, depending on the people running it. Do you agree?

Casey: Personally, I don't think Division should exist. I think it's awful and should be disbanded. I agree that it's only as good or bad as the people running it, but my problem is that there are no checks and balances. There's nobody to keep them in line. It's kind of a strange way of working. So I don't think Division is a good place, I don't think it should exist any longer than it takes to get rid of it.

ETonline: What are you excited for Nikita fans to see in the coming weeks?

Casey: I'm really excited for them to see Owen and Sean in the field together. That's a really interesting episode because they have to rely on each other but they don't like each other. As a SEAL, Sean's training tells him that the life of his partner in the field is more important than his own, so for that person to be Owen is difficult for Sean. I don't know what Owen’s like. I think he's a bit of a loose cannon [because] his loyalty is to Nikita, and he'd do anything for her.

Nikita airs Fridays at 8 p.m. on The CW.

Read More..

WHO: Small cancer risk after Fukushima accident

LONDON (AP) — People exposed to the highest doses of radiation during Japan's Fukushima nuclear plant disaster in 2011 may have a slightly higher risk of cancer but one so small it probably won't be detectable, the World Health Organization said in a report released Thursday.

A group of experts convened by the agency assessed the risk of various cancers based on estimates of how much radiation people at the epicenter of the nuclear disaster received, namely those directly under the plumes of radiation in the most affected communities in Fukushima, a rural agricultural area about 150 miles (240 kilometers) north of Tokyo.

Some 110,000 people living around the Fukushima Dai-ichi nuclear plant were evacuated after the massive earthquake and tsunami on March 11, 2011 knocked out the plant's power and cooling systems, causing meltdowns in three reactors and spewing radiation into the surrounding air, soil and water.

In the new report, the highest increases in risk appeared for people exposed as infants to radiation in the most heavily affected areas. Normally in Japan, the lifetime risk of developing cancer of an organ is about 41 percent for men and 29 percent for women. The new report said that for infants in the most heavily exposed areas, the radiation from Fukushima would add about 1 percentage point to those numbers.

"These are pretty small proportional increases," said Richard Wakeford of the University of Manchester, one of the authors of the report.

"The additional risk is quite small and will probably be hidden by the noise of other (cancer) risks like people's lifestyle choices and statistical fluctuations," he said. "It's more important not to start smoking than having been in Fukushima."

Experts had been particularly worried about a spike in thyroid cancer, since iodine released in nuclear accidents is absorbed by the thyroid, especially in children. After the Chernobyl disaster, about 6,000 children exposed to radiation later developed thyroid cancer because many drank contaminated milk after the accident.

In Japan, dairy radiation levels were closely monitored, but children are not big milk drinkers there.

WHO estimated that women exposed as infants to the most radiation after the Fukushima accident would have a 70 percent higher chance of getting thyroid cancer in their lifetimes. But thyroid cancer is extremely rare, one of the most treatable cancers when caught early, and the normal lifetime risk of developing it is about 0.75 percent. That risk would be half of one percentage point higher for women who got the highest radiation doses as infants.

Wakeford said the increase in such cancers may be so small it will probably not be observable.

For people beyond the most directly affected areas of Fukushima, Wakeford said the projected risk from the radiation dropped dramatically. "The risks to everyone else were just infinitesimal."

David Brenner of Columbia University in New York, an expert on radiation-induced cancers, said that although the risk to individuals is tiny outside the most heavily exposed areas, some cancers might still result, at least in theory. But they'd be too rare to be detectable in overall cancer rates, he said.

Brenner said the numerical risk estimates in the WHO report were not surprising. He also said they should be considered imprecise because of the difficulty in determining risk from low doses of radiation. He was not connected to the WHO report.

Some experts said it was surprising that any increase in cancer was even predicted.

"On the basis of the radiation doses people have received, there is no reason to think there would be an increase in cancer in the next 50 years," said Wade Allison, an emeritus professor of physics at Oxford University, who was not connected to the WHO report. "The very small increase in cancers means that it's even less than the risk of crossing the road," he said.

WHO acknowledged in its report that it relied on some assumptions that may have resulted in an overestimate of the radiation dose in the general population.

Gerry Thomas, a professor of molecular pathology at Imperial College London, accused the WHO of hyping the cancer risk.

"It's understandable that WHO wants to err on the side of caution, but telling the Japanese about a barely significant personal risk may not be helpful," she said.

Thomas said the WHO report used inflated estimates of radiation doses and didn't properly take into account Japan's quick evacuation of people from Fukushima.

"This will fuel fears in Japan that could be more dangerous than the physical effects of radiation," she said, noting that people living under stress have higher rates of heart problems, suicide and mental illness.

In Japan, Norio Kanno, the chief of Iitate village, in one of the regions hardest hit by the disaster, harshly criticized the WHO report on Japanese public television channel NHK, describing it as "totally hypothetical."

Many people who remain in Fukushima still fear long-term health risks from the radiation, and some refuse to let their children play outside or eat locally-grown food. Kanno accused the report of exaggerating the cancer risk and stoking fear among residents.

"I'm enraged," he said.

___

Mari Yamaguchi in Tokyo and AP Science Writer Malcolm Ritter in New York contributed to this report.

Read More..

Wall Street edges higher, Dow and S&P records a hurdle

NEW YORK (Reuters) - Stocks rose modestly on low volume on Thursday after strong economic data, but the proximity of record highs for the Dow and the S&P 500 gave investors a reason to keep gains in check.

The U.S. economy grew slightly in the fourth quarter, reversing an earlier estimate showing contraction, and a drop in new claims for unemployment benefits last week added to a string of data that suggests the economy improved early this year.

Still, an even higher revision to GDP data was expected, and the jobless claims extended a trend baked into stock prices.

The low volume shows a lack of conviction from new buyers, according to Ken Polcari, director of the NYSE floor division at O'Neil Securities in New York.

Polcari the recent gains are the reaction to Monday's selloff, but there are not enough catalysts to take indexes much higher.

"Don't expect the market to hit new highs today," he said.

In afternoon trading, just over 3 billion shares had changed hands on the New York Stock Exchange, the Nasdaq and NYSE MKT.

The Dow was within striking distance of its record high after a year-to-date advance of almost 8 percent. The Dow Jones Transportation Average <.djt>, seen as a bet on future growth, is up 13 percent this year, and the 20-stock index hit a record intraday high earlier on Thursday.

The Dow Jones industrial average <.dji> rose 61.32 points or 0.44 percent to 14,136.69. The S&P 500 <.spx> gained 8.03 points or 0.53 percent to 1,524.02. The Nasdaq Composite <.ixic> added 17.14 points or 0.55 percent, to 3,179.67.

The Dow's record closing high, set on October 9, 2007, stands at 14,164.53, while the Dow's intraday record high, set on October 11, 2007, stands at 14,198.10.

The S&P 500 has gained more than 2 percent this week and is on track to post its fourth straight month of gains.

Equity markets suffered steep losses earlier in the week on concerns about the impact of an Italian election on the European economy, but stocks bounced back on strong data and recent comments by Federal Reserve Chairman Ben Bernanke that showed continued support for the Fed's economic stimulus policy.

Gains in Limited Brands and Netflix , both up nearly 4 percent, led the way among consumer stocks. Shares of Limited Brands, the parent of retailers Victoria's Secret and Bath & Body Works, shot up 3.8 percent to $46.21. The stock of video streaming service Netflix jumped 3.8 percent to $191.24.

In contrast, shares of J.C. Penney , however, slid 14.9 percent to $18.01 after the department store operator reported a steep drop in sales on Wednesday. Groupon Inc also fell on weak revenue, with the daily deals company's stock off 19.2 percent at $4.83.

Cablevision shares tumbled 8.8 percent to $14.11 after the cable provider took a $100 million hit on costs related to Superstorm Sandy and posted deeper video customer losses than expected.

On a positive note, Mylan Inc shares were on track to close at their highest ever after the generic drugmaker posted a 25 percent rise in fourth-quarter profit and said it will buy a unit of India's Strides Arcolab Ltd. Mylan's stock gained 4.2 percent to $29.78.

Investors were keeping an eye on the debate in Washington over U.S. government budget cuts that will take effect starting Friday if lawmakers fail to reach agreement on spending and taxes. President Barack Obama and Republican congressional leaders arranged last-ditch talks to prevent the cuts, but expectations were low that any deal would emerge.

With 93 percent of the S&P 500 companies having reported results so far, 69.5 percent have beaten profit expectations, compared with a 62 percent average since 1994 and 65 percent over the past four quarters, according to Thomson Reuters data.

Fourth-quarter earnings for S&P 500 companies are estimated to have risen 6.2 percent, according to the data, above a 1.9 percent forecast at the start of the earnings season.

(Reporting by Rodrigo Campos; Additional reporting by Ryan Vlastelica; Editing by Nick Zieminski and Jan Paschal)

Read More..

Bobby Brown Sentenced to Jail for DUI

Bobby Brown has been sentenced to 55 days in jail for his second DUI conviction in a year.

The 44-year-old singer received the sentence Tuesday after his lawyer entered a plea of no contest on his behalf to charges that Brown was under the influence and driving on a suspended license when he was arrested in October 2012.

PICS: Star Sightings

He was ordered to report to jail beginning March 20 and was also placed on four years of informal probation and will be required to attend Alcoholics Anonymous sessions each week.

Brown also pleaded no contest last year to another charge of driving under the influence in connection with an arrest last April.

VIDEO: Bobby Brown on Anniversary of Whitney's Death

Read More..

Vt. lye victim gets new face at Boston hospital

BOSTON (AP) — The 2007 chemical attack left the Vermont nurse unrecognizable to anyone who knew her.

But now Carmen Blandin Tarleton's face has changed again following a facial transplant this month.

Doctors at Brigham & Women's Hospital in Boston said Wednesday that the 44-year-old's surgery included transplanting a female donor's facial skin to Tarleton's neck, nose and lips, along with facial muscles, arteries and nerves.

"I know how truly blessed I am, and will have such a nice reflection in the mirror to remind myself what selfless really is," Tarleton wrote on her blog Wednesday.

The Thetford, Vt., woman suffered burns on more than 80 percent of her body and was blinded after her estranged husband attacked her with a baseball bat and doused her with lye in 2007.

Tarleton, who once worked as a transplant nurse, has undergone more than 50 surgeries since the attack, including work to restore some of her vision.

The latest surgery took 15 hours and included a team of more than 30 medical professionals. The lead surgeon, Bohdan Pomahac, called her injuries among the worst he's seen in his career.

"Carmen is a fighter," the doctor said Wednesday. "And fight she did."

Pomahac's team has performed five facial transplants at the hospital. He said the patient is recovering very well and is in great spirits as she works to get stronger.

He said she was very pleased when she saw her face for the first time, and that her appearance will not match that of the late donor's face.

"I think she looks amazing, but I'm biased," he said with a smile.

The donor's family wants to remain anonymous, but released a statement through a regional donor bank saying that her spirit would live on through Tarleton and three other organ recipients.

The estranged husband, Herbert Rodgers, pleaded guilty in 2009 in exchange for a prison sentence of at least 30 years.

Read More..

Derek Hough Talks Maksim Chmerkovskiy Dancing with the Stars Exit

ET caught up with the brand-new cast of Dancing with the Stars season 16 after their big Good Morning America announcement Tuesday morning, where one looming question couldn't be ignored -- can the show survive without popular pro dancer Maksim Chrmerkovskiy?

"It's the nature of the show, you know. People aren't asked back certain seasons and come back later," pro dancer Derek Hough says. "It'll be a different dynamic but that's what it's about I suppose. I'm excited for the new pros."

Pics: The Complete List of 'Dancing with the Stars' Winners

However, he did share that the producers of the ABC hit are trying to bring back a more "positive" vibe to the show -- and it's no secret that Maksim was a controversial figure in seasons past.

"We had a meeting with the producers, and like, we really want to bring the innocence back to the show and the positivity and the fun and not -- [yes] be competitive -- but we don't want to make it a negative competitiveness," Derek shares.

Derek, already a three-time winner of the coveted mirror ball trophy, is paired up with country star Kellie Pickler this season, who just happens to be the first crossover contestant from American Idol!

"It's exciting to kind of get the whole 'pick Pickler' thing going again and I don't know, it's great to step outside your comfort zone and try something new and I think it's when you do things like that you grow," an excited Kellie tells ET.

Related: 'DWTS' Season 16 Cast Revealed!

Check out the video to hear thoughts from brand-new DWTS contestants like Olympic gymnast Aly Raisman, D.L. Hughley, Andy Dick, NFL wide receiver Jacoby Jones, Wynonna Judd and Real Housewives' Lisa Vanderpump.

Dancing with the Stars premieres March 26 on ABC.

Read More..

FDA halts Amgen study after teen patient death

WASHINGTON (AP) — Federal health regulators say they have halted Amgen's studies of its thyroid drug Sensipar after the death of a 14-year-old patient in a company trial.

The Food and Drug Administration says it is gathering information about the death, but has shut down all studies of the drug in children.

Sensipar is approved for adults to treat over-activity of the parathyroid gland. Amgen Inc. had been studying the drug to see whether it works in children.

The FDA says in a statement it is unclear whether Amgen's drug had a role in the patient's death, but it is reminding doctors to prescribe it carefully.

The agency says doctors should monitor patients' calcium levels to make sure they don't fall to dangerous levels.

Read More..

Italy election forecasts point to political gridlock

ROME (Reuters) - Conflicting early forecasts of the result of Italy's election on Monday raised the specter of deadlock in parliament that could paralyze a new government and re-ignite the euro zone crisis.

Officials from both center and left warned that such gridlock could make Italy ungovernable and force new elections.

Opinion polls have long pointed to the center-left of Pier Luigi Bersani winning the lower house, but projections from RAI state television showed Silvio Berlusconi's center right in front in the Senate - which has equal lawmaking power - but unable to form a majority.

RAI showed the center-left well short of a majority in the Senate even in coalition with Monti, who was seen slumping to only 19 out of 315 elected Senators against a massive 65 for the anti-establishment 5-Star Movement of comedian Beppe Grillo.

Senate votes are counted before the lower house.

The latest projections ran counter to earlier telephone polls that showed the center left taking a strong lead in the Senate as well as the lower house.

Italian financial markets took fright after rising earlier on hopes for a stable and strong center-left led government, probably backed by outgoing technocrat premier Mario Monti.

Such government is seen by investors as the best guarantee of measures to combat a deep recession and stagnant growth in the euro zone's third largest economy, which is pivotal to stability in the currency union.

Berlusconi's declared aim is to win enough power in the Senate to paralyze a center-left administration.

The benchmark spread between Italian 10-year bonds and their German equivalent widened from below 260 basis points to above 280 and the Italian share index lost all its previous gains.

"These projections suggest that we are heading for an ungovernable situation", said Mario Secchi, a candidate for Monti's centrist movement.

Stefano Fassina, chief economic official for Bersani's center-left, said: "The scenario from the projections we have seen so far suggest there will be no stable government and we would need to return to the polls."

The earlier telephone polls on Sky and Rai television after voting ended at 3 p.m. (1400 GMT/9 a.m. ET) had shown the center left 5-6 points ahead of the center right in both Senate and lower house, with Grillo taking third place.

Adding to the confusion, official results from more than 50 percent of polling stations showed the center-left ahead with 32.7 percent against 29.5 for the center-right in the Senate race. The partial official count is often not representative because of the order in which votes are counted regionally.

Italy's electoral laws guarantee a strong majority in the lower house to the party or coalition that wins the biggest share of the national vote.

However the Senate, elected on a region-by-region basis, is more complicated and the result will turn on four key battleground regions. Projections from LA 7 showed Berlusconi winning in three of them: Lombardy, Sicily and Campania.

A Sky television projection showed him strongly ahead in the rich northern region Lombardy, which returns the largest number of Senators, with 38.8 percent against 27.6 for the center left.

BITTER CAMPAIGN

A bitter campaign, fought largely over economic issues, has made some investors fear a return of the kind of debt crisis that took the euro zone close to disaster and brought the technocrat Monti to office, replacing the scandal-plagued Berlusconi, in 2011.

Monti helped save Italy from a debt crisis when Rome's borrowing costs were spiraling out of control, but the polls and projections suggested few Italians now see him as the savior of the country, in its longest recession for 20 years.

A surge in protest votes for Grillo's 5-Star Movement had raised uncertainty about the chances of a stable government that could fend off the danger of a renewed euro zone crisis.

Grillo's movement rode a huge wave of voter anger about both the pain of Monti's austerity program and a string of political and corporate scandals. It had particular appeal for a frustrated younger generation shut out of full-time jobs.

"I'm sick of the scandals and the stealing," said Paolo Gentile, a 49-year-old Rome lawyer who voted for 5-Star.

"We need some young, new people in parliament, not the old parties that are totally discredited."

Bad weather, including heavy snow in some areas, was thought to have hampered the turnout in Italy's first post-war election to be held in winter. This could have favored the center left, whose voters tend to be more committed than those on the right, which has strong support among older people.

Berlusconi, a 76-year-old media tycoon, pledged sweeping tax cuts and accused Monti of being a puppet of German Chancellor Angela Merkel in a media blitz that halved the lead of the center left in opinion polls since the start of the year.

Whatever government emerges will inherit an economy that has been stagnant for much of the past two decades and problems ranging from record youth unemployment to a dysfunctional justice system and a bloated public sector.

(Additional reporting by Stefano Bernabei, Steve Scherer, Gavin Jones and Giuseppe Fonte in Rome and Lisa Jucca in Milan; Writing by Barry Moody; Editing by Robin Pomeroy and Philippa Fletcher)

Read More..

Janet Jackson Married Wissam Al Mana

Rumors that Janet Jackson is planning her wedding to Wissam Al Mana have been flying fast and furious for weeks now. There's only one problem: they're already married!

PHOTOS - The Most Glamorous Oscar Gowns

In their first joint statement as a couple, Janet Jackson and Wissam Al Mana confirm the news exclusively to ET, saying, "The rumours regarding an extravagant wedding are simply not true. Last year we were married in a quiet, private, and beautiful ceremony."

VIDEO - Prince Michael Jackson is ET's Newest Correspondant

"Our wedding gifts to one another were contributions to our respective favourite children’s charities. We would appreciate that our privacy is respected and that we are allowed this time for celebration and joy. With love, Wissam and Janet"

Congratulations to the happy couple!

Photo by world-renowned photographer, Marco Glaviano.

Read More..

Wall Street drops on Italian election uncertainty

NEW YORK (Reuters) - Stocks fell on Monday, reversing course from earlier gains as elections in Italy stoked concerns a divided parliament could disrupt the country's fiscal reforms and the euro zone's stability.

Early forecasts of the results were conflicting, as opinion polls indicated the center-left of Pier Luigi Bersani winning the lower house, but projections from RAI state television showed Silvio Berlusconi's center right in front in the Senate - which has equal lawmaking power - but unable to form a majority.

The resulting gridlock in parliament could force new elections and sent the euro currency lower against both the dollar and yen.

"Most likely we are looking at a second election, so it's delayed, but at the margin it is a negative," said Tim Ghriskey, chief investment officer of Solaris Group in Bedford Hills, New York.

"The question is, what happens with Italy and that uncertainty is out there, that is really what you've seen in the sell-off here."

Earlier polls pointing to a center-left victory boosted stocks in Milan and other European markets, as well as helping to lift the S&P 500 to a session high of 1,525.84 on optimism Italy would continue to pay down its debt.

However, the benchmark S&P index remained near highs not seen in five years, as bets on a stronger U.S. economy have given equities support. The S&P 500's slight fall last week was the first weekly drop after a seven-week string of gains to start the year.

Banks and other financial stocks were among the worst performers on worries about the sector's exposure to Italy's massive debt. The KBW Bank Index <.bkx> fell 1.1 percent.

The Dow Jones industrial average <.dji> dropped 92.14 points, or 0.66 percent, to 13,908.43. The Standard & Poor's 500 Index <.spx> dropped 11.65 points, or 0.77 percent, to 1,503.95. The Nasdaq Composite Index <.ixic> dropped 12.65 points, or 0.40 percent, to 3,149.17.

Barnes & Noble Inc shares jumped 10.6 percent to $14.94 after the bookseller's chairman offered to buy its declining retail business.

The Nasdaq received support from Amgen Inc , up 4.9 percent at $91.03, after rival Affymax issued a voluntary recall of its only drug, an anemia treatment that competes with Amgen's top-selling red blood cell booster, Epogen. Affymax shares slumped 84.6 percent to $2.55.

The FTSEurofirst-300 index of top European shares <.fteu3> unofficially closed up 0.04 percent and Italy's main FTSE MIB <.ftmib> ended up 0.7 percent after earlier gaining near 4 percent.

U.S. equities will face a test with the looming debate over so-called sequestration, U.S. government budget cuts that will take effect starting on Friday if lawmakers fail to reach an agreement over spending and taxes. The White House issued warnings about the harm the cuts are likely to inflict on the economy if enacted.

"Sitting out there is the one thousand pound gorilla - the sequester issue - and certainly nothing is happening there," Ghriskey said.

Lowe's Companies Inc lost 1.6 percent to $37.08 after the home improvement retailer posted fourth-quarter earnings.

With 83 percent of the S&P 500 companies having reported results so far, 69 percent beat profit expectations, compared with a 62 percent average since 1994 and 65 percent over the past four quarters, according to Thomson Reuters data.

Fourth-quarter earnings for S&P 500 companies are estimated to have risen 6 percent, according to the data, above a 1.9 percent forecast at the start of the earnings season.

(Editing by Kenneth Barry, Jan Paschal and Nick Zieminski)

Read More..

Independent Spirit Award Winners 2013

The 2013 Film Independent Spirits Awards were handed out in Santa Monica, CA today and lots of Oscar frontrunners cemented their status by dominating in their categories once more.

Check out all the winners below:

Best Feature

Beasts of the Southern Wild

Bernie

Keep the Lights On

Moonrise Kingdom

Silver Linings Playbook

BEST FEMALE LEAD

Linda Cardellini, Return

Emayatzy Corinealdi, Middle of Nowhere

Jennifer Lawrence, Silver Linings Playbook

Quvenzhane Wallis, Beasts of the Southern Wild

Mary Elizabeth Winstead, Smashed

BEST MALE LEAD

Jack Black, Bernie

Bradley Cooper, Silver Linings Playbook

John Hawkes, The Sessions

Thure Lindhardt, Keep the Lights On

Matthew McConaughey, Killer Joe

Wendell Pierce, Four

BEST SUPPORTING FEMALE

Rosemarie DeWitt, Your Sister's Sister

Ann Dowd, Compliance

Helen Hunt, The Sessions

Brit Marling, Sound of My Voice

Lorraine Toussaint, Middle of Nowhere

BEST SUPPORTING MALE

Matthew McConaughey, Magic Mike

David Oyelowo, Middle of Nowhere

Michael Pena, End of Watch

Sam Rockwell, Seven Psychopaths

Bruce Willis, Moonrise Kingdom

BEST DIRECTOR

Wes Anderson, Moonrise Kingdom

Julia Loktev, The Loneliest Planet

David O. Russell, Silver Linings Playbook

Ira Sachs, Keep the Lights On

Benh Zeitlin, Beasts of the Southern Wild

BEST SCREENPLAY

Wes Anderson & Roman Coppola, Moonrise Kingdom

Zoe Kazan, Ruby Sparks

Martin McDonagh, Seven Psychopaths

David O. Russell, Silver Linings Playbook

Ira Sachs, Keep the Lights On

For the full list of winners, click here.

Read More..

Investors face another Washington deadline

NEW YORK (Reuters) - Investors face another Washington-imposed deadline on government spending cuts next week, but it's not generating the same level of fear as two months ago when the "fiscal cliff" loomed large.

Investors in sectors most likely to be affected by the cuts, like defense, seem untroubled that the budget talks could send stocks tumbling.

Talks on the U.S. budget crisis began again this week leading up to the March 1 deadline for the so-called sequestration when $85 billion in automatic federal spending cuts are scheduled to take effect.

"It's at this point a political hot button in Washington but a very low level investor concern," said Fred Dickson, chief market strategist at D.A. Davidson & Co. in Lake Oswego, Oregon. The fight pits President Barack Obama and fellow Democrats against congressional Republicans.

Stocks rallied in early January after a compromise temporarily avoided the fiscal cliff, and the Standard & Poor's 500 index <.spx> has risen 6.3 percent since the start of the year.

But the benchmark index lost steam this week, posting its first week of losses since the start of the year. Minutes on Wednesday from the last Federal Reserve meeting, which suggested the central bank may slow or stop its stimulus policy sooner than expected, provided the catalyst.

National elections in Italy on Sunday and Monday could also add to investor concern. Most investors expect a government headed by Pier Luigi Bersani to win and continue with reforms to tackle Italy's debt problems. However, a resurgence by former leader Silvio Berlusconi has raised doubts.

"Europe has been in the last six months less of a topic for the stock market, but the problems haven't gone away. This may bring back investor attention to that," said Kim Forrest, senior equity research analyst at Fort Pitt Capital Group in Pittsburgh.

OPTIONS BULLS TARGET GAINS

The spending cuts, if they go ahead, could hit the defense industry particularly hard.

Yet in the options market, bulls were targeting gains in Lockheed Martin Corp , the Pentagon's biggest supplier.

Calls on the stock far outpaced puts, suggesting that many investors anticipate the stock to move higher. Overall options volume on the stock was 2.8 times the daily average with 17,000 calls and 3,360 puts traded, according to options analytics firm Trade Alert.

"The upside call buying in Lockheed solidifies the idea that option investors are not pricing in a lot of downside risk in most defense stocks from the likely impact of sequestration," said Jared Woodard, a founder of research and advisory firm condoroptions.com in Forest, Virginia.

The stock ended up 0.6 percent at $88.12 on Friday.

If lawmakers fail to reach an agreement on reducing the U.S. budget deficit in the next few days, a sequester would include significant cuts in defense spending. Companies such as General Dynamics Corp and Smith & Wesson Holding Corp could be affected.

General Dynamics Corp shares rose 1.2 percent to $67.32 and Smith & Wesson added 4.6 percent to $9.18 on Friday.

EYES ON GDP DATA, APPLE

The latest data on fourth-quarter U.S. gross domestic product is expected on Thursday, and some analysts predict an upward revision following trade data that showed America's deficit shrank in December to its narrowest in nearly three years.

U.S. GDP unexpectedly contracted in the fourth quarter, according to an earlier government estimate, but analysts said there was no reason for panic, given that consumer spending and business investment picked up.

Investors will be looking for any hints of changes in the Fed's policy of monetary easing when Fed Chairman Ben Bernake speaks before congressional committees on Tuesday and Wednesday.

Shares of Apple will be watched closely next week when the company's annual stockholders' meeting is held.

On Friday, a U.S. judge handed outspoken hedge fund manager David Einhorn a victory in his battle with the iPhone maker, blocking the company from moving forward with a shareholder vote on a controversial proposal to limit the company's ability to issue preferred stock.

(Additional reporting by Doris Frankel; Editing by Kenneth Barry)

Read More..

Egypt parliament election start moved to April 22

Katherine Webb, girlfriend of Alabama quarterback A.J. McCarron, made headlines when she was spotted by ESPN's Brent Musberger at the National Championship game earlier this year.Now, the 23-year-old model - recently featured in the pages of the annual Sports Illustrated Swimsuit Edition and a castmember on ABC's upcoming reality diving show, "Splash" -- explains how she's handling her sudden fame.

Read More..

Buzzmakers: Prince Michael Reports for ET and Mindy McCready Dies

What had ETOnline readers buzzing this week?

1. Prince Michael Jackson is New ET Correspondent

Having grown up in show business, Prince Michael proved to be a gifted interviewer as he conducted his first sit-down as an ET correspondent.

Michael Jackson's 16-year-old son impressed Oz the Great and Powerful stars James Franco and Zach Braff as well as director Sam Raimi with his confidence and competence on his first assignment.

"You're doing awesome," Braff gushed. "You're a natural."

Prince Michael returned the compliment, praising their work in the fantasy flick and getting Franco to shed some light on how he approached playing the lead role of Oscar Diggs, a small-time circus magician with dubious ethics.

"I saw that his particular transformation would allow for comedy," Franco explained. "Because he's a conman -- that would get him into a lot of awkward situations that could be played for comedy."

The movie imagines the origins of L. Frank Baum's beloved character from The Wizard of Oz. After Oscar Diggs (Franco) is hurled away from dusty Kansas to the vibrant Land of Oz, he first thinks he's hit the jackpot -- until he meets three witches, Theodora (Mila Kunis), Evanora (Rachel Weisz) and Glinda (Michelle Williams), who are not convinced he is the great wizard everyone's been expecting.

2. Country Music Stars Mourn Mindy McCready's Death

The country music community is mourning the loss of one of their own. Country crooner Mindy McCready was found dead of apparent suicide on Sunday, Feb. 17, at her Arkansas home. She was 37. Needless to say, this has caused an outpouring of sympathetic tweets from McCready's musician peers.

Here are some of the stars' reactions to the tragic news:

LeAnn Rimes: "Mindy and I both started our careers around the same time. We worked with a lot of the same people, so we ended up spending lots of time around one another. She was always so kind and very protective of me, like a big sis. My heart is broken that she's gone."

Carrie Underwood: "I grew up listening to Mindy McCready...so sad for her family tonight. Many prayers are going out to them..."

Clay Aiken: "I listened admiringly to Mindy McCready growing up. May she finally be at peace and lend her beautiful voice to heaven's."

Lady Antebellum's Hillary Scott: "My heart is breaking hearing of the loss of Mindy McCready. Pray for her 2 precious little boys...may God's peace & protection be on them!"

Jason Aldean: "Just heard about Mindy McCready. My thoughts and prayers are with her 2 boys and her family."

Big and Rich's John Rich: "Very sad to hear about Mindy McCready. When I was in Lonestar she was our label mate and we were friends. A tragic end to a talented life."

Wynona Judd: "Oh my! Mindy. Dear sweet girl. This is so sad. It just breaks my heart what addiction continues to take from this life. Addiction is a dis EASE and not a character flaw. When the pain becomes too much, it causes people to want that pain to stop. This is just so Unbelievable and so sad. God be with the family and those babies. Surround them with your grace & mercy. Sleep in Heavenly peace Mindy."

Martina McBride: "So sad."

Chely Wright: "Really really sad to learn the news about Mindy McCready. I will pray for her children and I hope that people are gentle with her memory."

Gretchen Peters: "So sad to hear about Mindy McCready. I met her in the first flush of her early career. This is a hard business. Sometimes success is poison."

3. Mark Hamill Reveals He's in Talks to Appear in New 'Star Wars'

Mark Hamill's new movie Sushi Girl hits DVD and Blu-ray this week, and while talking about the project, the Star Wars legend was more than happy to provide ETonline with an update on his involvement with the in-development Star Wars VII – and what he thinks of those planned spinoff movies…

"It's all very, very exciting and so unexpected," says Hamill. "I think that's the quality I like about it most – it's like getting a pair of pants out of the closet you haven't worn in three years and finding a $20 bill in the pocket. It's just so unexpected."

First off, will he appear in Star Wars VII? "They're talking to us," he reveals. "George [Lucas] wanted to know whether we'd be interested. He did say that if we didn't want to do it, they wouldn't cast another actor in our parts – they would write us out. … I can tell you right away that we haven't signed any contracts. We're in the stage where they want us to go in and meet with Michael Arndt, who is the writer, and Kathleen Kennedy, who is going to run Lucasfilm. Both have had meetings set that were postponed -- on their end, not mine. They're more busy than I am."

Hamill, 61, says he's intrigued about where the new trilogy could go but says he knows nothing about the storyline: "I probably learn more from Entertainment Tonight than I do directly from Lucasfilm – like for instance, when George told us he wanted to do the next trilogy, he didn't tell us it was going to be done for Disney. He saved that little nugget, and I read it online like anybody else."

As for his thoughts about the next trilogy's tone, "I said to George that I wanted to go back to the way it was, in the sense that ours was much more carefree and lighthearted and humorous – in my opinion, anyway. And another thing I'd want to make sure of is are we going to have the whole gang back? Is Carrie and Harrison and Billy Dee and Tony Daniels, everybody that's around from the original [returning]? I want to make sure that everybody's on board here, rather than just one. I guess I'll have to tune into your show to figure out who's on board."

In terms of where we'll pick up with Luke Skywalker in Star Wars VII, "I'm assuming, because I haven't talked to the writers, that these movies would be about our offspring -- like my character would be sort of in the Obi-Wan range [as] an influential character. … When I found out [while making the original trilogy] that ultimate good news/bad news joke – the good news is there's a real attractive, hot girl in the universe; the bad news is she's your sister – I thought, 'Well, I'm going to wind up like Sir Alec [Guinness]. I'm going to be a lonely old hermit living out in some kind of desert igloo with a couple of robots.'"

Hamill concludes of the next movie, "I hope they find the right balance of CGI with practical effects. I love props, I love models, miniatures, matte paintings -- I'm sort of old school. I think if you go too far in the direction of CGI it winds up looking like just a giant a video game, and that's unfortunate. … If they listen to me at all, it'll be, 'Lighten up and go retro with the way it looks.'"

As for those confirmed stand-alone Star Wars films, which may follow the adventures of a young Han Solo, Boba Fett and Yoda, Hamill observes, "That's really smart. Then you're more like James Bond pictures, where they come out and it's not an investment of a three-movie arc. … It's so rich, that [Star Wars] universe, in terms of quirkiness and oddball [nature]. We would talk about that [on the original film's set]. We'd go like, 'That little band that's playing in the Cantina, what's their story?! I mean, are they a traveling band? Are they the house band? Who's their manager?' They didn't have names when we first were talking about them. Now they're called, like, Sy Snootles – they come up with names down the road when they have to name toys."

So what spinoff movie would Mark Hamill like to see? "Oh, I don't know, set it on the Wookiee planet -- although that might be prohibitively expensive with that many Wookiees," he says with some resignation. After a little more thought, he muses, "That's what I would love. You pick the most insignificant little [character] – there's this little hawk-beaked character that's somewhere in Jabba's palace, I can't even remember what function he served -- but that's what I would think. You pick something that almost nobody remembers or knows about -- and then have a movie about him! You could probably put about 500 different character's names on a big, giant dart board, throw a dart, and say, 'Okay, wherever it lands we've got to make him the central character.'"
After a hearty laugh, Hamill adds, "I hope we don't overstay our welcome."

4. Nina Dobrev Reflects on Shocking 'Vampire Diaries' Death

Death has loomed large over Elena Gilbert since The Vampire Diaries pilot, but absolutely nothing will compare with the pain she's forced to endure now that her brother, Jeremy, has fallen victim to vampires.

The shocking death not only devastated fans, but the actors -- Steven McQueen included -- as well. And anyone assuming TVD finds a way to make the best of a bad situation is wrong. Dead wrong. According to Nina Dobrev things are about to get real dark for Elena, whose grief will make her unrecognizable to fans in the coming weeks.

ETonline: This season has been a thrill from the start. What's your feeling about season four?

Nina Dobrev: It's been really cool, especially because you always hear actors say doing a TV show for X amount of years can be boring and repetitive, but over the last four years, Elena has been changing and evolving and growing so much. Julie [Plec, executive producer] has done such an incredible job of keeping it fresh and exciting and making me excited to come to work every day. Especially this season -- and especially with the death of Jeremy. Between last week's episode and this week's, it's been very challenging for me as an actress, but very fulfilling. It's an emotional rollercoaster and I had to go to some dark places.

ETonline: What was your reaction to finding out Jeremy would be killed?

Dobrev: I think we were all shocked and surprised, but that's the show -- it's a vampire show, people have to die all the time. And for Elena, it was very important that she lose Jeremy for what she's about to go through. It becomes a big part of her journey. I know Steven was very bummed, but also excited because he had a lot to do leading up to it -- his character grew and became so strong. It's bittersweet but made for some amazing television.

ETonline: In many ways, Jeremy was the person who really kept Elena tethered to her humanity. Will this loss threaten to make Elena embrace the less desirable sides of vampirism?

Dobrev: Jeremy was the last person she had left, so it's very likely that Elena could go off the deep end now that she doesn't have the one thing that kept her human. Elena wants to protect the people she loves and saw this new-found strength as a way to protect everyone. But, in this case, she couldn't protect Jeremy and lost the only family member she had left. She won't take it lightly. It's going to destroy her.

ETonline: Jeremy was also one of the only remaining characters who touched everyone in Mystic Falls. Will his death, in some ways, reinforce the group?

Dobrev: They do come together, but everyone is sort of walking on pins and needles around Elena so they don't trigger something and send her into a psychotic break. They live in a mystical world, so just because Jeremy's dead, it doesn't mean he's really dead in her mind. So she's looking for any solution she can to bring him back -- Elena is basically mentally unstable, going a little crazy and everyone is trying to help.

ETonline: Obviously Elena still misses Jenna and Alaric, but I would imagine losing Jeremy has a much more profound and prolonged effect on her. True?

Dobrev: Losing Jeremy really, really, really changes Elena. Sometimes people recover from tragedy and sometimes they don't -- but it's a long journey for her. Elena's mourning peroid is much different than any I've ever seen depicted on TV before. She goes off the deep end and spirals downwards into a black hole of death and sadness and misery. I mean, your instinct is right when you asked if we'll see an Elena who embraces her vampire side to a different degree. It's an Elena we haven't seen before, and you'll be shocked, quite frankly. I was very surprised where the episodes take her because it's almost like she's a completely different person that you won't recognize to some degree.

5. Fergie Reveals: I'm Pregnant!

Congratulations are in order for Fergie and Josh Duhamel, as the couple announced this week that they're expecting their first child!

"Josh & Me & BABY makes three," she Tweeted, along with the hashtag #MyLovelyBabyBump

Fergie and Duhamel married on January 10, 2009, after five years of dating.

Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.

Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.

"This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it's very kind and gentle on the patients — there's no hair loss, no nausea, no vomiting," said Dr. Melody Cobleigh of Rush University Medical Center. "It's a revolutionary way of treating cancer."

Cobleigh helped conduct the key studies of the drug at the Chicago facility.

The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.

The approval will help Roche's Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.

Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.

FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.

Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs.

FDA specifically approved the drug for patients with advanced breast cancer who have already been treated with Herceptin and taxane, a widely used chemotherapy drug. Doctors are not required to follow FDA prescribing guidelines, and cancer researchers say the drug could have great potential in patients with earlier forms of breast cancer

Kadcyla will carry a boxed warning, the most severe type, alerting doctors and patients that the drug can cause liver toxicity, heart problems and potentially death. The drug can also cause severe birth defects and should not be used by pregnant women.

Kadcyla was developed by South San Francisco-based Genentech using drug-binding technology licensed from Waltham, Mass.-based ImmunoGen. The company developed the chemical that keeps the drug cocktail together and is scheduled to receive a $10.5 million payment from Genentech on the FDA decision. The company will also receive additional royalties on the drug's sales.

Shares of ImmunoGen Inc. rose 2 cents to $14.32 in afternoon trading. The stock has ttraded in a 52-wek range of $10.85 to $18.10.

Read More..

Investors face another Washington deadline

NEW YORK (Reuters) - Investors face another Washington-imposed deadline on government spending cuts next week, but it's not generating the same level of fear as two months ago when the "fiscal cliff" loomed large.

Investors in sectors most likely to be affected by the cuts, like defense, seem untroubled that the budget talks could send stocks tumbling.

Talks on the U.S. budget crisis began again this week leading up to the March 1 deadline for the so-called sequestration when $85 billion in automatic federal spending cuts are scheduled to take effect.

"It's at this point a political hot button in Washington but a very low level investor concern," said Fred Dickson, chief market strategist at D.A. Davidson & Co. in Lake Oswego, Oregon. The fight pits President Barack Obama and fellow Democrats against congressional Republicans.

Stocks rallied in early January after a compromise temporarily avoided the fiscal cliff, and the Standard & Poor's 500 index <.spx> has risen 6.3 percent since the start of the year.

But the benchmark index lost steam this week, posting its first week of losses since the start of the year. Minutes on Wednesday from the last Federal Reserve meeting, which suggested the central bank may slow or stop its stimulus policy sooner than expected, provided the catalyst.

National elections in Italy on Sunday and Monday could also add to investor concern. Most investors expect a government headed by Pier Luigi Bersani to win and continue with reforms to tackle Italy's debt problems. However, a resurgence by former leader Silvio Berlusconi has raised doubts.

"Europe has been in the last six months less of a topic for the stock market, but the problems haven't gone away. This may bring back investor attention to that," said Kim Forrest, senior equity research analyst at Fort Pitt Capital Group in Pittsburgh.

OPTIONS BULLS TARGET GAINS

The spending cuts, if they go ahead, could hit the defense industry particularly hard.

Yet in the options market, bulls were targeting gains in Lockheed Martin Corp , the Pentagon's biggest supplier.

Calls on the stock far outpaced puts, suggesting that many investors anticipate the stock to move higher. Overall options volume on the stock was 2.8 times the daily average with 17,000 calls and 3,360 puts traded, according to options analytics firm Trade Alert.

"The upside call buying in Lockheed solidifies the idea that option investors are not pricing in a lot of downside risk in most defense stocks from the likely impact of sequestration," said Jared Woodard, a founder of research and advisory firm condoroptions.com in Forest, Virginia.

The stock ended up 0.6 percent at $88.12 on Friday.

If lawmakers fail to reach an agreement on reducing the U.S. budget deficit in the next few days, a sequester would include significant cuts in defense spending. Companies such as General Dynamics Corp and Smith & Wesson Holding Corp could be affected.

General Dynamics Corp shares rose 1.2 percent to $67.32 and Smith & Wesson added 4.6 percent to $9.18 on Friday.

EYES ON GDP DATA, APPLE

The latest data on fourth-quarter U.S. gross domestic product is expected on Thursday, and some analysts predict an upward revision following trade data that showed America's deficit shrank in December to its narrowest in nearly three years.

U.S. GDP unexpectedly contracted in the fourth quarter, according to an earlier government estimate, but analysts said there was no reason for panic, given that consumer spending and business investment picked up.

Investors will be looking for any hints of changes in the Fed's policy of monetary easing when Fed Chairman Ben Bernake speaks before congressional committees on Tuesday and Wednesday.

Shares of Apple will be watched closely next week when the company's annual stockholders' meeting is held.

On Friday, a U.S. judge handed outspoken hedge fund manager David Einhorn a victory in his battle with the iPhone maker, blocking the company from moving forward with a shareholder vote on a controversial proposal to limit the company's ability to issue preferred stock.

(Additional reporting by Doris Frankel; Editing by Kenneth Barry)

Read More..

Abe: Japan acting calmly in island dispute with China

WASHINGTON (Reuters) - Japanese Prime Minister Shinzo Abe on Friday said he told President Barack Obama in a meeting that Japan would act calmly in its row with China over tiny islands in the East China Sea claimed by both Asian countries.

"I explained that we have always been dealing with this issue ... in a calm manner," he said through a translator, while sitting next to Obama in the White House Oval Office.

"We will continue to do so and we have always done so," he said.

Tension has raised fears of an unintended military incident near the islands, known as the Senkaku in Japan and the Diaoyu in China. Washington says the islets fall under a U.S.-Japan security pact, but it is eager to avoid a clash in the region.

Abe said the existence of the Japan-U.S. alliance was a stabilizing factor in the area.

"We agreed that we would stay in close coordination with each other in dealing with such issues and other issues," he said.

Obama, in his remarks to reporters, said Japan was one of the United States' closest allies. He said the two men would discuss trade and other economic issues and agreed that their top priority was economic growth.

Obama declined to answer a reporter's question on whether they would discuss the Japanese yen.

Expectations for Abe's economic programs, especially monetary easing, have cut some 10 percent off the yen's value against the U.S. dollar since Abe took office, raising concern that Japan is weakening its currency to export its way out of recession.

Obama and Abe also discussed North Korea and agreed to cooperate at the United Nations over the issue. Abe said the two men also talked about additional sanctions against North Korea, which tested a nuclear bomb last week in defiance of U.N. resolutions.

(Editing by Vicki Allen)

Read More..

Dwayne Johnson Talks 'Snitch'

Dwayne Johnson is forced to drive for a ruthless drug cartel in the gritty action-thriller Snitch, in theaters today, and the towering star with a heart of gold tells ET, "I would go through heaven and hell to protect my child."

Pics: They Dated?! Surprising Celebrity Hookups

"At the heart of this film it is about family, and I would do anything to protect my family," says Johnson. "It's what we do as adults – we protect our children from harm, from danger."
At the center of the film is a serious showpiece, the edge-of-your-seat big rig chase, and we asked Johnson if he was able to drive the truck himself.

Flashing his trademark grin, he replied, "You bet your ass I know how to drive that big rig. I loved driving that. The big rig became a character in and of itself in this movie."

Snitch finds Johnson as a concerned father faced with a dramatic choice after his teenage son is wrongly accused of a drug distribution crime. With his boy facing a minimum prison sentence of 10 years, the desperate and determined Johnson makes a deal with the U.S. attorney to work as an undercover informant and infiltrate a dangerous drug cartel (whose key player is played by Benjamin Bratt). Willing to risk everything to free his son, can Johnson make it out alive? Susan Sarandon, Barry Pepper and Jon Bernthal also star.

Video: Johnson Talks 'G.I. Joe: Retaliation'

Johnson adds, "Because [the movie is based on a] true story, I wanted to make sure that all of the elements are preserved and respected."

Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.

Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.

"This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it's very kind and gentle on the patients — there's no hair loss, no nausea, no vomiting," said Dr. Melody Cobleigh of Rush University Medical Center. "It's a revolutionary way of treating cancer."

Cobleigh helped conduct the key studies of the drug at the Chicago facility.

The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.

The approval will help Roche's Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.

Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.

FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.

Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs.

FDA specifically approved the drug for patients with advanced breast cancer who have already been treated with Herceptin and taxane, a widely used chemotherapy drug.

Kadcyla will carry a boxed warning, the most severe type, alerting doctors and patients that the drug can cause liver toxicity, heart problems and potentially death. The drug can also cause severe birth defects and should not be used by pregnant women.

Kadcyla was co-developed by South San Francisco-based Genentech and ImmunoGen Inc., of Waltham, Mass. ImmunoGen developed the technology that binds the drug ingredients together and is scheduled to receive a $10.5 million payment from Genentech on the FDA decision. The company will also receive additional royalties on the drug's sales.

Shares of ImmunoGen Inc. slipped 8 cents to $14.22 in afternoon trading. They have traded in a 52-wek range of $10.85 to $18.10.

Read More..

French, Malian forces fight Islamist rebels in Gao

GAO, Mali (Reuters) - French and Malian troops fought Islamists on the streets of Gao and a car bomb exploded in Kidal on Thursday, as fighting showed little sign of abating weeks before France plans to start withdrawing some forces.

Reuters reporters in Gao in the country's desert north said French and Malian forces fired at the mayor's office with heavy machineguns after Islamists were reported to have infiltrated the Niger River town during a night of explosions and gunfire.

French Defense Minister Jean-Yves Le Drian told a news conference in Brussels that Gao was back under control after clashes earlier in the day.

"Malian troops supported by French soldiers killed five jihadists and the situation is back to normal," he said.

In Kidal, a remote far north town where the French are hunting Islamists, residents said a car bomb killed two. A French defense ministry source reported no French casualties.

French troops dispatched to root out rebels with links to al Qaeda swiftly retook northern towns last month. But they now risk being bogged down in a guerrilla conflict as they try to help Mali's weak army counter bombings and raids.

"There was an infiltration by Islamists overnight and there is shooting all over the place," Sadou Harouna Diallo, Gao's mayor, told Reuters by telephone earlier in the day, saying he was not in his office at the time.

Gao is a French hub for operations in the Kidal region, about 300 km (190 miles) northeast, where many Islamist leaders are thought to have retreated and foreign hostages may be held.

"They are black and two were disguised as women," a Malian soldier in Gao who gave his name only as Sergeant Assak told Reuters during a pause in heavy gunfire around Independence Square.

Six Malian military pickups were deployed in the square and opened fire on the mayor's office with the heavy machineguns. Two injured soldiers were taken away in an ambulance.

French troops in armored vehicles later joined the battle as it spilled out into the warren of sandy streets, where, two weeks ago, they also fought for hours against Islamists who had infiltrated the town via the nearby river.

Helicopters clattered over the mayor's office, while a nearby local government office and petrol station was on fire.

A Gao resident said he heard an explosion and then saw a Malian military vehicle on fire in a nearby street.

Paris has said it plans to start withdrawing some of its 4,000 troops from Mali next month. But rebels have fought back against Mali's weak and divided army, and African forces due to take over the French role are not yet in place.

Islamists abandoned the main towns they held but French and Malian forces have said there are pockets of Islamist resistance across the north, which is about the size of France.

CAR BOMB

Residents reported a bomb in the east of Kidal on Thursday.

"It was a car bomb that exploded in a garage," said one resident who went to the scene but asked not to be named.

"The driver and another man were killed. Two other people were injured," he added.

A French defense ministry official confirmed there had been a car bomb but said it did not appear that French troops, based at the town's airport, had been targeted.

Earlier this week, a French soldier was killed in heavy fighting north of Kidal, where French and Chadian troops are hunting Islamists in the Adrar des Ifoghas mountains, which border Algeria.

Operations there are further complicated by the presence of separatist Tuareg rebels, whose rebellion triggered the fighting in northern Mali last year but were sidelined by the better-armed Islamists.

Having dispatched its forces to prevent an Islamist advance south in January, Paris is eager not to become bogged down in a long-term conflict in Mali. But their Malian and African allies have urged French troops not to pull out too soon.

(Additional reporting by Emanuel Braun in Gao, Adama Diarra in Bamako, David Lewis and John Irish in Dakar and Adrian Croft in Brussels; Writing by David Lewis; Editing by Jason Webb and Roger Atwood)

Read More..

Josh Brolin Praises Diane Lane Before Split

News of Josh Brolin and Diane Lane's split after eight years of marriage came as a surprise to many in Hollywood, especially since Josh just recently sang the praises of his spouse while ruminating about how to maintain a successful relationship in the Hollywood spotlight during his recent Gangster Squad junket. Watch the video…

Pics: Top 10 Biggest Divorce Payouts

Diane stars in the upcoming summer blockbuster-to-be Man of Steel as Martha Kent, and Brooke shared a laugh with Josh during the junket that she's a "Woman of Steel."

"She's a very strong woman, extremely strong," the 45-year-old star acknowledged before steering the conversation towards how he hadn't yet seen the new trailer from the Superman film, adding that he's "always excited to see" Diane's performances.

Brooke then more directly asked how the couple manages "a successful relationship in Hollywood in the spotlight," and he replied gamely, "Because we're not really in the spotlight. I mean, we are in times like this [junket interview], but, you know, there's one light. We just do our own thing, and we always have. And we're not in L.A. all the time, we're up north a lot of the time where I grew up, so, you know, you just do what you do. You don't play up into the hype so much."

Video: Diane Lane After Husband Josh Brolin's Arrest

Stay tuned to ET for more news on Josh Brolin and Diane Lane's split.

Read More..

Flu shot did poor job against worst bug in seniors

ATLANTA (AP) — For those 65 and older, this season's flu shot is only 9 percent effective against the most common and dangerous flu bug, according to a startling new government report.

Flu vaccine tends to protect younger people better than older ones and never works as well as other kinds of vaccines. But experts say the preliminary results for seniors are disappointing and highlight the need for a better vaccine.

For all age groups, the vaccine's effectiveness is moderate at 56 percent, which is nearly as well as other flu seasons, the Centers for Disease Control and Prevention said Thursday.

For those 65 and older, it is 27 percent effective against the three strains in the vaccine, the lowest in about a decade but not far below from what's expected. But the vaccine did a particularly poor job of protecting older people against the harshest flu strain, which is causing most of the illnesses this year. CDC officials say it's not clear why.

Vaccinations are now recommended for anyone over 6 months, and health officials stress that some vaccine protection is better than none at all. While it's likely that older people who were vaccinated are still getting sick, many of them may be getting less severe symptoms.

"Year in and year out, the vaccine is the best protection we have," said CDC flu expert Dr. Joseph Bresee.

To be sure, the preliminary data for seniors is less than definitive. It is based on fewer than 300 people scattered among five states.

But it will no doubt surprise many people that the effectiveness is that low, said Michael Osterholm, a University of Minnesota infectious disease expert who has tried to draw attention to the need for a more effective flu vaccine.

Among infectious diseases, flu is considered one of the nation's leading killers. On average, about 24,000 Americans die each flu season, according to the CDC.

This flu season started in early December, a month earlier than usual, and peaked by the end of year. Older people are most vulnerable to flu and its complications, and the nation has seen some of the highest hospitalization rates for people 65 and older in a decade.

Flu viruses tend to mutate more quickly than others, and it's not unusual for multiple strains to be spreading at the same time. A new vaccine is formulated each year targeting the three strains expected to be the major threats. But that involves guesswork.

Because of these challenges, scientists tend to set a lower bar for flu vaccine. While childhood vaccines against diseases like measles are expected to be 90 or 95 percent effective, a flu vaccine that's 60 to 70 percent effective in the U.S. is considered pretty good.

By that standard, this year's vaccine is OK. The 56 percent effectiveness figure means people have a 56 percent lower chance of winding up at the doctor for treatment of flu symptoms.

For seniors, a flu vaccine is considered pretty good if it's in the 30 to 40 percent range, said Dr. Arnold Monto, a University of Michigan flu expert.

Older people have weaker immune systems that don't respond as well to flu shots. That's why a high-dose version was recently made available for those 65 and older. The new study was too small to show whether that made a difference this year.

The CDC estimates are based on about 2,700 people who got sick in December and January. The researchers traced back to see who had gotten flu shots and who hadn't. An earlier study put the vaccine's overall effectiveness slightly higher, at 62 percent.

The CDC's Bresee said there's a danger in providing preliminary results because it may result in people doubting — or skipping — flu shots. But the data was released to warn older people who got shots that they may still get sick and shouldn't ignore any serious flu-like symptoms, he said.

The new data highlights an evolution in how experts are evaluating flu vaccine effectiveness. For years, it was believed that if the viruses in the vaccine matched the ones spreading around the country, then the vaccine would be effective. This year's shot was a good match to the bugs going around this winter, including the harsher H3N2 that tends to make people sicker.

But the season proved to be a moderately severe one, with many illnesses occurring in people who'd been vaccinated.

____

Online:

CDC report: http://www.cdc.gov/mmwr

Read More..